U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07621367) titled 'Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease' on May 25.

Brief Summary: This multicenter, randomized, double-blind, placebo-controlled clinical trial aimed to investigate the efficacy and safety of gut oxygen therapy in the treatment of ischemic-hypoxic bowel disease using deep intestinal catheterization as a targeted route for gut oxygen delivery.

Study Start Date: May 28

Study Type: INTERVENTIONAL

Condition: Ischemic Bowel Disease Hypoxic Events

Intervention: OTHER: Oxygen 30 %

Patients will receive 250mL of oxygen (30%) through a deep intestinal catheterization four times a day for 5 days.

OTHER: Air

Patients wil...